Neoadjuvant Treatment for Gastric Cancer

Surgery is still considered to be the mainstay for the treatment of localized gastric cancer with negative margins (R0-resection) and an adequate lymph-node-dissection (D2-lymphadenectomy). Unfortunately, most cases of gastric cancer are only diagnosed at an advanced stage due to frequent recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuhmacher, Christoph, Reim, Daniel, Novotny, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705135/
https://www.ncbi.nlm.nih.gov/pubmed/23844320
http://dx.doi.org/10.5230/jgc.2013.13.2.73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705135/
https://www.ncbi.nlm.nih.gov/pubmed/23844320
http://dx.doi.org/10.5230/jgc.2013.13.2.73

Ejemplares similares